CoChat

Bridging Translation by Improving Preclinical Study Design in AKI

Open access
de Caestecker, Mark, Humphreys, Ben D., Liu, Kathleen D., Fissell, William H., Cerda, Jorge, Nolin, Thomas D., Askenazi, David, Mour, Girish, Harrell, Frank E., Pullen, Nick, Okusa, Mark D., Faubel, Sarah · 2015 · Journal of the American Society of Nephrology
Cited by 99

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Despite extensive research, no therapeutic interventions have been shown to prevent AKI, accelerate recovery of AKI, or reduce progression of AKI to CKD in patients. This failure in translation has led investigators to speculate that the animal models being used do not predict therapeutic responses in humans. Although this issue continues to be debated, an important concern that has not been addressed is whether improvements in preclinical study design can be identified that might also increase the likelihood of translating basic AKI research into clinical practice using the current models. In this review, we have taken an evidence-based approach to identify common weaknesses in study design and reporting in preclinical AKI research that may contribute to the poor translatability of the findings. We focused on use of N-acetylcysteine or sodium bicarbonate for the prevention of contrast-induced AKI and use of erythropoietin for the prevention of AKI, two therapeutic approaches that have been extensively studied in clinical trials. On the basis of our findings, we identified five areas for improvement in preclinical study design and reporting. These suggested and preliminary guidelines may help improve the quality of preclinical research for AKI drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2015070832

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 99

Metadata

Authors
de Caestecker, M., Humphreys, B. D., Liu, K. D., Fissell, W. H., Cerda, J., Nolin, T. D., Askenazi, D., Mour, G., Harrell, F. E., Pullen, N., Okusa, M. D., & Faubel, S.
Venue
Journal of the American Society of Nephrology
Published
2015-12
Volume
26
Issue
12
Pages
2905-2916
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2195071417
Cited by
99
References
19
FWCI
8.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bridging Translation by Improving Preclinical Study Design in AKI. https://app.cochat.ai/papers/10.1681/asn.2015070832
The paper
de Caestecker, M., Humphreys, B. D., Liu, K. D., Fissell, W. H., Cerda, J., Nolin, T. D., Askenazi, D., Mour, G., Harrell, F. E., Pullen, N., Okusa, M. D., & Faubel, S. (2015). Bridging Translation by Improving Preclinical Study Design in AKI. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2015070832

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.